MAPT and Parkinson disease: In terms of differential diagnostic capacity of tau PET tracers, the first‐generation tau tracer [18F]AV‐1451 presents with favorable binding to PSP over PD patients, although these results have a large amount of heterogeneity, indicated by high I2 values.